ALX1-11 50 mcg
CL1-11-821
Phase 2 small_molecule completed
Quick answer
ALX1-11 50 mcg for Osteoporosis is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Osteoporosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed